Kaufman S S, Blain P L, Park J H, Tuma D J
Center for Human Nutrition, Veterans Administration Medical Center, Omaha, Nebraska.
Am J Physiol. 1990 Jan;258(1 Pt 1):G129-37. doi: 10.1152/ajpgi.1990.258.1.G129.
Efficient receptor-mediated endocytosis of asialoglycoprotein by mature liver requires participation of microtubules that convey newly internalized ligand to lysosomes for degradation and receptor back to plasma membrane to continue endocytosis. To ascertain whether microtubular participation in asialoglycoprotein endocytosis is altered during development, we compared endocytosis of 125I-labeled asialoorosomucoid (ASOR) in neonatal rat hepatocytes to that in adult cells, with and without microtubular disruption by colchicine. Control experiments demonstrated that 125I-ASOR degradation in neonatal hepatocytes occurred at 70% of the adult rate during continuous endocytosis, although neonatal surface receptors were only approximately 40% as numerous. Colchicine disruption of microtubules reduced 125I-ASOR degradation and steady-state intracellular ASOR more in adults during continuous endocytosis. Degradation of 125I-ASOR prebound to surface receptors was equally impaired by colchicine in the two groups. Continuous ASOR endocytosis by colchicine-treated adult hepatocytes progressively depleted their surface receptors but minimally in neonates. Unlike colchicine, the protonophore monensin markedly impaired receptor recycling as well as postinternalization ligand trafficking in both neonates and adults. Thus these experiments demonstrate that asialoglycoprotein processing proceeds as efficiently in neonatal as in adult hepatocytes despite a reduced surface receptor population. Microtubules are required to maintain receptors on cell surface as well as for postinternalization trafficking in adult cells. During development, only the latter process substantially requires microtubules, indicating that microtubular participation in protein trafficking is selectively, not uniformly, diminished at this time in life.
成熟肝脏通过受体介导的高效内吞作用摄取去唾液酸糖蛋白,这一过程需要微管参与,微管将新内化的配体转运至溶酶体进行降解,并将受体运回质膜以继续内吞作用。为了确定在发育过程中微管参与去唾液酸糖蛋白内吞作用的情况是否发生改变,我们比较了新生大鼠肝细胞和成年细胞对125I标记的去唾液酸血清类黏蛋白(ASOR)的内吞作用,实验中分别使用了秋水仙碱破坏微管和未破坏微管的情况。对照实验表明,在持续内吞过程中,新生肝细胞中125I-ASOR的降解速度为成年细胞的70%,尽管新生肝细胞表面受体数量仅约为成年细胞的40%。在持续内吞过程中,秋水仙碱破坏微管对成年细胞中125I-ASOR降解和稳态细胞内ASOR的减少作用更大。秋水仙碱对两组中预先结合在表面受体上的125I-ASOR的降解均有同等程度的损害。秋水仙碱处理的成年肝细胞持续进行ASOR内吞作用会逐渐耗尽其表面受体,但对新生肝细胞的影响最小。与秋水仙碱不同,质子载体莫能菌素显著损害了新生和成年细胞中的受体循环以及内化后配体的运输。因此,这些实验表明,尽管新生肝细胞表面受体数量减少,但去唾液酸糖蛋白的处理过程在新生肝细胞中与成年肝细胞中一样高效。微管对于维持成年细胞表面的受体以及内化后运输是必需的。在发育过程中,只有后者这一过程在很大程度上需要微管,这表明在生命的这个阶段,微管参与蛋白质运输的作用是选择性地而非均匀地减弱。